The University of Lahore
Lahore, Punjab Province, 54000, Pakistan
NCT Number: NCT07244900
The goal of this study is to determine the effects of action observation therapy with conventional physical therapy on freezing gait and functional limitation in participants with Parkinson's disease.
Looking for future studies?
Notify Me50 year–80 year
All sexes
Interventional
Not applicable
Lahore, Punjab Province, 54000, Pakistan
Parkinson's disease is a neurodegenerative disorder that is characterized by rigidity, tremors, and bradykinesia, along with non-motor dysfunction. The exercise rehabilitation has a positive impact on motor and non-motor functions in individuals with Parkinson's disease. Conventional physical therapy (CPT) that involves isometric exercises, stretching techniques, and strength and balance training is useful to improve the severity of functional mobility and freezing of gait. In action observation therapy (AOT), small video clips of different goal-directed tasks were added to rehabilitation to determine the combined effects on outcome.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The participants were included based on the UK Parkinson's Disease Society Brain Bank diagnostic criteria, with clinical findings supporting the diagnosis. The eligible participants were
Exclusion criteria
The exclusion criteria were
Group A received conventional physical therapy treatment. The CPT program consists of isometric exercises, stretching, and strength training based on the patient's physical condition and the severity of functional mobility and freezing of Gait.
Group B was given action observation therapy with conventional physical therapy treatment. In AOT, the therapist showed small video clips of different goal-directed tasks to participants, and they were asked to follow every step and movement. The therapist maintained the patient's attention with verbal feedback
Time frame: The assessment was made at baseline before the treatment session, and any change in mobility status was observed at the end of 6th week and 12th week after the intervention.
The TUG is an efficient test that measures mobility and balance, requiring participants to rise from a chair, walk 3 meters, turn, walk back, and sit down. The time taken to complete this sequence is recorded, with longer times indicating potential mobility issues. A score of more than or equal to fourteen seconds indicates a high risk of falls.
Time frame: The freezing of gait was assessed at baseline, and any change in it was measured at the end of 6th week and 12th week after the intervention.
The FOG-Q is a reliable tool for evaluating the effectiveness of treatment intervention on FOG for Parkinson's disease. The questionnaire consists of 6 items designed to assess the severity of freezing of gait. Each item is rated on a five-point Likert scale, with '0' indicating no symptoms and '4' indicating the most severe symptoms. The total score can range from 0 to 24, with higher scores indicating greater severity of freezing of gait.
University of Lahore
Other
Effects Of Conventional Physical Therapy With And Without Action Observation Therapy On Freezing Of Gait And Functional Mobility In Participants With Parkinson's Disease: A Randomised Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04362228
Alzheimer Disease, Basal Ganglia Diseases
Hamilton, Ontario, Canada
View Trial DetailsNCT03563807
Basal Ganglia Diseases, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT03775538
Basal Ganglia Diseases, Brain Diseases
Helsinki, Finland
View Trial DetailsNCT04491383
Basal Ganglia Diseases, Brain Diseases
Singapore
View Trial Details